APA (7th ed.) Citation

Gisleskog, P. O., Valenzuela, B., Treijtel, N., Deshpande, S., Henninger, T., & Perez‐Ruixo, J. J. (2025). Population Pharmacokinetic and Exposure‐Response Analyses of Ibrutinib Combined With Bendamustine and Rituximab in Patients With Mantle Cell Lymphoma. CPT: Pharmacometrics & Systems Pharmacology, 14(10), 1562. https://doi.org/10.1002/psp4.70061

Chicago Style (17th ed.) Citation

Gisleskog, Per Olsson, Belén Valenzuela, Nicoline Treijtel, Sanjay Deshpande, Todd Henninger, and Juan José Perez‐Ruixo. "Population Pharmacokinetic and Exposure‐Response Analyses of Ibrutinib Combined With Bendamustine and Rituximab in Patients With Mantle Cell Lymphoma." CPT: Pharmacometrics & Systems Pharmacology 14, no. 10 (2025): 1562. https://doi.org/10.1002/psp4.70061.

MLA (9th ed.) Citation

Gisleskog, Per Olsson, et al. "Population Pharmacokinetic and Exposure‐Response Analyses of Ibrutinib Combined With Bendamustine and Rituximab in Patients With Mantle Cell Lymphoma." CPT: Pharmacometrics & Systems Pharmacology, vol. 14, no. 10, 2025, p. 1562, https://doi.org/10.1002/psp4.70061.